The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...

For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.

The heart of the complaints from employees is severe ... “Endless tasks demanded of [pharmacists] at CVS make it nearly impossible to assist patients the way they deserve and increases the ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...

Ronan Clarke is tipping Armagh to prove their doubters wrong and show they are not one hit wonders. The Orchard County ...

Strawberry Hills Pharmacy owner Daniel Jones reacted Thursday to a recent Federal Trade Commission report which showed pharmacy benefit managers made billions of dollars by inflating the price of ...

Discover the inspiring work of Cullompton’s Keystone Project, where small acts of kindness help locals rebuild their lives, ...

Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) ...

Three major drug middlemenneedlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 billion ...

The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...